Why Amarin Stock Is Sinking Today

Shares of Amarin (NASDAQ: AMRN) were trading down by 8.2% as of 11:03 a.m. ET Friday after having fallen by as much as 19.2% earlier in the session. It was the second consecutive day of declines after additional data from an exploratory post hoc sub-analysis from the company's Reduce-It cardiovascular outcomes study of Vascepa were published on the website of the medical journal Circulation.

The published data wasn't great news for the biotech company. The study's findings raise doubts about whether or not Vascepa is actually effective in preventing heart attacks.

Source Fool.com